- Home
- Anti Malarial drug
WHO ends hydroxychloroquine trial for COVID-19
Scientists find no survival benefit of treating COVID-19 patients with HCQ
Lancet retracts study that linked HCQ to increased death risk
WHO approves trial of HCQ for potential COVID-19 treatment
WHO suspends COVID-19 trials of HCQ over safety issues
Hydroxychloroquine linked to increased risk of death in hospitalized Covid-19 patients: Study
Covid-19: West Bengal to ramp up the production of Hydroxychloroquine
India to export HCQ only to foreign govts and not to pvt companies: Sources
Latest Additions
Jayant Patil claims BJP used irrigation ‘scam’ to blackmail Ajit Pawar; Fadnavis, NCP chief hit back
Medical College expels 5 MBBS students from hostel for ragging juniors
Insulting women is in DNA of Cong leaders, alleges Jharkhand BJP
Man arrested from Delhi for calling up Pappu Yadav posing as aide of Lawrence Bishnoi
Tejasvi Surya hits out at Kharge, CMs of Cong-ruled states over poll promises